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Figure 1: Effect of PA on pAkt and pGSK-3β 48 h after the MCAO. 
A. Phospho-Akt concentration was unaffected in the ischemic brain upon pamoic acid treatment 
at 48 h after the MCAO The One-Way ANOVA, P>0.05 (Bonferroni multiple comparison test), 
values are means±s.e.m, n=4. B. PA treatment significantly increased the phosphorylation of 
GSK-3β after 48 h of MCAO. One-Way ANOVA, F(2/13)=4.769, *P=0.0284 (Bonferroni 














Figure 2: PA treatment reduces oxidative stress in the ischemic hemisphere 48 h after the 
MCAO. 
A. PA treatment reduced the nitric oxide concentration in the ischemic hemisphere 48 h after the 
MCAO. The One-Way ANOVA, F(2/12)=5.53, *P=0.0364 to 0.0464 (Bonferroni multiple 
comparison test), values are means±s.e.m, n=5. B. PA treatment increased autoxidation 
inhibition in the ischemic hemisphere 48 h after the MCAO. The One-Way ANOVA, 
F(2/12)=10.56, **P=0.0040 to 0.0083 (Bonferroni multiple comparison tests), values are 
means±s.e.m, (n for Sham =4, n for MCAO= 5, n for MCAO+PA=6). C.  PA treatment reduced 
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myeloperoxidase (MPO) activity in the ischemic hemisphere 48 h after the MCAO. The One-
Way ANOVA, F(2/11)=16.16, **P=0.0048, ***P=0.0005 (Bonferroni multiple comparison test), 
values are means±s.e.m,(n for Sham =4, n for MCAO= 4, n for MCAO+PA=6). 
D. PA treatment increased the catalase activity in the ischemic hemisphere 48 h after the MCAO. 
The One-Way ANOVA, F(2/12)=6.875, *P=0.0214, (Bonferroni multiple comparison test), values 
are means±s.e.m, n=5. E. PA treatment increased the GSH activity in the ischemic hemisphere 
48 h after the MCAO. The One-Way ANOVA, F(2/17)=9.232, *P=0.0484, **P=0.0019 
(Bonferroni multiple comparison test), values are means±s.e.m, (n for Sham =6, n for MCAO= 
8, n for MCAO+PA=6). F. PA treatment The effect of PA on malondialdehyde (MDA) 
concentration in the ischemic brain 48 h after the MCAO was insignificant. The One-Way 
ANOVA, F(2/12)=3.981, P>0.05 (Bonferroni multiple comparison tests), values are means±s.e.m, 
(n for Sham =4, n for MCAO= 5, n for MCAO+PA=6). 
 
